Real-World Treatment Efficacy of Ribociclib or Palbociclib Plus Fulvestrant in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study
Titel:
Real-World Treatment Efficacy of Ribociclib or Palbociclib Plus Fulvestrant in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study
Auteur:
Kahraman, Seda Erul, Enes Gumusay, Ozge Guven, Deniz Can Aksoy, Sercan Basaran, Gul Seyyar, Mustafa Sahin, Elif Cabuk, Devrim Bayram, Ertugrul Paydas, Semra Demirel, Burcin Cakan Yaren, Arzu Gulbagci, Burcu Hacibekiroglu, Ilhan Baytemur, Naziyet Kose Demirci, Umut Davarci, Sena Ece Demir, Hacer Mocan, Eda Eylemer Dogan, Ozlem Cilbir, Ebru Yasar, Alper Bayoglu, Ibrahim Vedat Hizal, Mutlu Kayikcioglu, Erkan Cetin, Bulent Acar, Omer Erdogan, Atike Pinar Keskinkilic, Merve Yavuzsen, Tugba Unal, Olcun Umit Yilmaz, Funda Dogan, Mutlu Orhan, Sibel Oyucu Cubukcu, Erdem Erol, Cihan Sakalar, Teoman Dulgar, Ozgecan Karakas, Yusuf Ozkanli, Gulhan Duman, Berna Bozkurt Isik, Deniz Karaoglanoglu, Muge Okutur, Sadi Kerem Yildirim, Nilgun Aydin, Esra Uluc, Basak Oyan Keser, Murat Bilgin, Burak Aksoy, Asude Eren, Onder Kalkan, Nurhan Onal Er, Muhammed Muhiddin Yucel, Hakan Sunar, Veli Paksoy, Nail Aydin, Dincer Turhal, Nazim Serdar Menekse, Serkan Kut, Engin Aykan, Musa Baris Ozdemir, Ozlem Ozcelik, Melike Iriagac, Yakup Selcukbiricik, Fatih Inal, Ali Karadurmus, Nuri Akinci, Muhammed Bulent Sendur, Mehmet Ali Nahit